The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

<div>Forest plot of the outcome of BMI reduction effect in overweight/obese. PCOS patients. EXE: exenatide; LIRA: liraglutide; MET: metformin; COMBI: combination, represented GLP-1RAs combined with MET treatment; WMD: weighted mean difference.</div>

International Journal of Endocrinology

fig4

Figure 4

Figure 4: The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis 

Figure 4 | The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis 